[Clinical evaluation of cefbuperazone in complicated urinary tract infection].
Cefbuperazone, a new cephamycin antibiotic, was used in 13 complicated UTI cases. The drug was given at a dose of 1 g in 100 ml of physiological saline solution twice a day for 5 - 14 days and judged for its clinical effect in 11 cases on days 5 - 7 according to the criteria of the UTI committee. Overall clinical efficacy was excellent in 3 cases, moderate in 2 cases and poor in 6 cases, the effectiveness rate was 45.5%. In laboratory findings, slightly elevated transaminase and A1-P were observed in 2 cases and 1 case, respectively.
D000328:Adult; D000368:Aged; D002513:Cephamycins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002513:Cephamycins; C035978:cefbuperazone